SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-048820
Filing Date
2018-08-01
Accepted
2018-08-01 17:17:49
Documents
5
Period of Report
2018-07-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-18010_18k.htm 8-K 38512
2 EX-1.1 a18-18010_1ex1d1.htm EX-1.1 739166
3 EX-99.1 a18-18010_1ex99d1.htm EX-99.1 12893
4 GRAPHIC g180101ka03i001.jpg GRAPHIC 2486
5 GRAPHIC g180101mmi001.jpg GRAPHIC 2920
  Complete submission text file 0001104659-18-048820.txt   799560
Mailing Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37686 | Film No.: 18985781
SIC: 2834 Pharmaceutical Preparations